21.5 C
Byron Shire
March 27, 2024

Doctors not convinced on medical cannabis

Latest News

Splendour 2024 cancelled

It's offical, Splendour in the Grass 2024 has been cancelled.

Other News

Workshop in Creative Writing For Beginners

Have you always felt like you have a novel in you, but don’t know where to start? Or have...

We just love him!

If you’re over 50 you might not be a fan of Tom Jones, but you can bet your mum is. If you’re under 40 you might not even know who he is, but your grandmother probably wet her pants at the mere mention of his name.

Way of the dog

One of the more disappointing aspects of the decline of Byron Bay, and I have a long list, is...

NORPA’s wild ride at Lismore Showgrounds

NORPA is taking audiences on an adventure outside the theatre once again, announcing it will stage its original work Wildskin in a warehouse space at the Lismore Showgrounds. A sensory, destination theatre experience, Wildskin inhabits an outrageous and unpredictable world that’s part bush-thriller, part road-trip and a whole lot of NORPA’s signature theatrical style.

Caper Byron Bay Food & Culture Festival

Caper Byron Bay Food & Culture Festival returns to Byron Bay in May, and this year ‘locals favourite’ pub...

Biz confidence up, says Business NSW

The state's peak body for business says confidence in the sector has increased but cost of living pressures continue to impact customer spending.

Doctors have been warned against rushing to prescribe medical cannabis despite Australians’ acceptance of its use. 
To date, the evidence on the effectiveness of medical cannabis remains “limited”, write Jennifer Martin and Associate Professor Yvonne Bonomo in an editorial for the Royal Australasian College of Physicians (RACP).

Published in the Medical Journal of Australia, they say the usual regulatory processes designed to protect patients from potential serious harms caused by medicinal cannabinoids must be adhered to.

“The pace and scale of the introduction of medicinal cannabis are unprecedented and have raised challenges for health professionals, not so much because of its known addictive and psychoactive properties, but because its introduction has not followed the usual research-based safety and effectiveness processes,” they wrote.

They argue there is a need for stronger and more streamlined guidelines in administering and supplying medical cannabis

.
In Australia, medicinal cannabis is legal but patient access is still very difficult.

The Therapeutic Goods Administration’s (TGA) Special Access Scheme (SAS) provides patient access to cannabis on compassionate grounds without the usual quality and safety data requirements.

This means approval is granted on a case-by-case basis provided the correct documentation is given by the prescribing doctor, says Dr John Lawson, a paediatric neurologist and conjoint senior lecturer at the University of New South Wales.

“The prescribing medical practitioner has several responsibilities, including providing informed consent and a treatment plan and monitoring, and complying with reporting requirements including reporting any adverse event to the TGA,” Dr Lawson said.

In the case of a child with epilepsy, “this means that general practitioners or paediatricians can only successfully apply via the SAS scheme with supporting documentation from a paediatric neurologist.”

He says there needs to be a balance between compassion and careful assessment for patients for whom cannabis products might be beneficial.

Already there is a body of evidence to support the use of medicinal cannabis for those suffering from chemotherapy-induced nausea, epilepsy, MS and Parkinson’s disease.

A recent trial published in The New England Journal of Medicine, led by Australian neurologist Professor Ingrid Scheffer, found cannabidiol – one of at least 113 compounds found in the cannabis plant – significantly reduced the severity and frequency of seizures in children with a rare, yet devastating form of epilepsy known as Dravet syndrome.

Last year, the Medical Cannabis Council called for more robust research to be done to ensure patients greater access in the future.


Support The Echo

Keeping the community together and the community voice loud and clear is what The Echo is about. More than ever we need your help to keep this voice alive and thriving in the community.

Like all businesses we are struggling to keep food on the table of all our local and hard working journalists, artists, sales, delivery and drudges who keep the news coming out to you both in the newspaper and online. If you can spare a few dollars a week – or maybe more – we would appreciate all the support you are able to give to keep the voice of independent, local journalism alive.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

We just love him!

If you’re over 50 you might not be a fan of Tom Jones, but you can bet your mum is. If you’re under 40 you might not even know who he is, but your grandmother probably wet her pants at the mere mention of his name.

Peter Garrett gives Bluesfest the nod

If I say the words ‘US Forces give the nod’, I can pretty much guarantee that you will hear the unmistakable voice of Peter Garrett ringing in your ears. Your head may even start to bob up and down a bit. 

Save Wallum finalist in NSW 2024 environment awards

The Save Wallum campaign has been named as a finalist in the Nature Conservation Council of NSW Environment Awards 2024. The award ceremony will be held in Sydney tonight, and Save Wallum spokesperson and ecologist James Barrie will be attending with Tegan Kitt, another founding member of the group.

New report highlights gaps in rural and remote health

The second annual Royal Flying Doctor Service ‘Best for the Bush, Rural and remote Health Base Line’ report has just been released. Presenting the latest data on the health of rural and remote Australians and evidence on service gaps, it identifies issues in urgent need of attention from service providers, funders, partners and policy makers.